<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758122/" ref="ordinalpos=2297&amp;ncbi_uid=5241856&amp;link_uid=PMC3758122" image-link="/pmc/articles/PMC3758122/figure/F6/" class="imagepopup">Fig. 6. PI-3K/Akt/JNK <span class="highlight" style="background-color:">pathway</span> is implicated in arsenite-mediated cell proliferation.  From: PI3K/Akt/JNK/c-Jun <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> is a Mediator for Arsenite-Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells. </a></div><br /><div class="p4l_captionBody"><b>a</b> and <b>b</b>. Beas-2B cells transfected with control vector, Δp85 or DN-Akt were treated with arsenite for 60 min and Western blot was then performed. The number was the relative blots density phosphor-JNK or c-Jun compared with total JNK or c-Jun. <b>c</b>. Beas-2B cells transfected with control vector, or DN-Akt or siCyclin D1 were exposed to various doses of arsenite for 48 h and ATP assay was performed. <b>d.</b> Beas-2B cells (1 × 103) were pre-treated with JNK inhibitor (25 μM) or LY98059 (50 μM) for 30 min and then exposed to arsenite for 48 hrs. Subsequently, ATP assay was performed. <b>e.</b> illustration of signaling pathway leading to cyclin D1 expression and cell proliferation upon arsenite exposure.</div></div>